Patents Assigned to Neuronz Ltd.
  • Methods to improve neural outcome
    Patent number: 6812208
    Abstract: A method for treatment or prophylaxis of a patient suffering from functional symptoms of Parkinson's disease, especially as a consequence of damage to dopaminergic neurons, by administering to the patient a neuroprotective amount of a peptide selected from the tripeptide gly-pro-glu (GPE) and analogs and mimetics thereof, preferably GPE. The GPE will usually be administered subsequent to the onset of Parkinson's disease but prior to the damage of said dopaminergic neurons.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: November 2, 2004
    Assignee: NeuronZ Ltd.
    Inventors: Peter D. Gluckman, Christopher E. Williams, Jian Guan, Rita V. M. Krishnamurthi
  • Regulation of neural enzymes
    Patent number: 6365573
    Abstract: This invention relates to the use of the tripeptide Gly-Pro-Glu (GPE) or analogs thereof for the treatment of conditions of the central nervous system (e.g. cerebral vasculitis) in which the amount of the neural enzymes nitric oxide synthetase (NOS) and/or glutamic acid decarboxylase (GAD) is reduced.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: April 2, 2002
    Assignee: Neuronz Ltd.
    Inventors: Peter D Gluckman, Christopher E. Williams, Jian Guan